About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/21/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/21/2021.

Myosfascial Trigger-Points and Effects on Neuromuscular Response

Clinicaltrials.gov identifier NCT03941054

Recruitment Status Enrolling by invitation

First Posted May 7, 2019

Last update posted May 7, 2019

Study Description

Brief summary:

The aim of this study is to analyze the effects of the treatment of the Myosfascial Trigger-Points detected in the gastrocnemius muscles on the neuromuscular response.

  • Condition or Disease:Myofascial Trigger Point Pain
  • Intervention/Treatment: Other: Pressure Release
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Interventional
  • Actual Enrollment: 29 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Outcomes Assessor)
  • Primary Purpose: Treatment
  • Official Title: Treatment of Myosfascial Trigger-Points of Gastrocnemius and Its Effects on the Neuromuscular Response
  • Actual Study Start Date: May 2019
  • Estimated Primary Completion Date: June 2019
  • Estimated Study Completion Date: June 2019
Arms and interventions
Arm Intervention/treatment
Experimental: Pressure Release
Digitopressure treatment of the Myosfascial Trigger Points
Other: Pressure Release
Subjets receive digitopressure during 90 seconds for the treatment of the Myosfascial Trigger Points
Outcome Measures
  • Primary Outcome Measures: 1. change of neuromuscular stiffness of the gastrocnemious muscles [ Time Frame: 10 minutes before the intervention, and 1 minute after the intervention ]
    biomechanical property of a muscle that characterizes the resistance to an external force that deforms its initial shape, using a "Myoton".
  • 2. change of elasticity of the gastrocnemious muscles [ Time Frame: 10 minutes before the intervention, and 1 minute after the intervention ]
    Biomechanical property of a muscle that characterizes the ability to recover its initial shape after the removal of the external force that lead to its deformation, using a "Myoton".
  • 3. change of relaxation of the gastrocnemious muscles [ Time Frame: 10 minutes before the intervention, and 1 minute after the intervention ]
    Time for a muscle to recover its shape from deformation after the removal of an external force, using a "Myoton".
  • Secondary Outcome Measures: 1. change of active dorsiflexion ROM [ Time Frame: 4 minutes before the intervention, and 6 minute after the intervention ]
    Active range of movement of the dorsiflexion of the ankle, using an inclinometer (degrees).
  • 2. change of pasive dorsiflexion ROM [ Time Frame: 2 minutes before the intervention, and 8 minute after the intervention ]
    Pasive range of movement of the dorsiflexion of the ankle, using an inclinometer (degrees).
  • 3. change of gastrocnemious strength [ Time Frame: 5 minutes before the intervention, and 5 minute after the intervention ]
    Isometric strength of the gastrocnemious muscles using a handheld dynamometer "microFET 2" (newtons).
  • 4. change of pain intensity [ Time Frame: 8 minutes before the intervention, and 2 minute after the intervention ]
    How much pressure needs to be applied to cause pain
  • 5. change of pressure-pain threshold [ Time Frame: 7 minutes before the intervention, and 3 minute after the intervention ]
    How much pain the pacient reports while a pressure of 1kg/cm²/s is being applied over his gastrocnemious muscle
Eligibility Criteria
  • Ages Eligible for Study: 18 to 40 Years (Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: Yes
Criteria

Inclusion Criteria:

- Subjets with both active or latent Myosfascial Trigger Points

Exclusion Criteria:

- Pregnant women

- Musculoskeletal problems in the last month

- Surgical interventions in he knee, hip, ankle, back or neck in tha last 6 months

- Psychological or nervous alterations

- Uncomprehension of the study protocol

Contacts and Locations
Contacts
Locations

Spain, Barcelona
Universitat Internacional de Catalunya
Sant Cugat Del Vallès

Sponsors and Collaborators

Universitat Internacional de Catalunya

Investigators

Principal Investigator: Albert Pérez-Bellmunt, PhD Anatomy lecturer

More Information
  • Responsible Party: Universitat Internacional de Catalunya
  • ClinicalTrials.gov Identifier: NCT03941054 History of Changes
  • Other Study ID Numbers: Protocol ID : P3/03
  • First Posted: May 7, 2019 Key Record Dates
  • Last Update Posted: May 7, 2019
  • Last Verified: May 2019
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: No
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Additional relevant MeSH terms: Myofascial Pain Syndromes